erasmus urology research
News & updates
New publication: Impact of comedonecrosis on prostate cancer outcome: a systematic review
Kaveri T S Aiyer 1, Lisa J Kroon 1, Geert J L H van Leenders 1 Abstract Cribriform architecture has been recognised as an independent parameter for prostate cancer outcome. Little is yet known on the added value of individual Gleason 5 growth patterns. Comedonecrosis...
New publication: The Europa Uomo Patient Reported Outcome Study 2.0-Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making
Lionne D F Venderbos 1, Sebastiaan Remmers 2, André Deschamps 3, John Dowling 3, Ernst-Günter Carl 3, Nuno Pereira-Azevedo 4, Monique J Roobol 2 Abstract Background: To further strengthen the voice of patients, Europa Uomo initiated the Europa Uomo Patient Reported...
Interview Amazing ErasmusMC NMIBC
Christiaan de Jong and Tahlita Zuiverloon were interviewed by Amazing ErasmusMC on their recently published study on non-muscle-invasive bladder cancer molecular subtypes.These subtypes can predict differential response to intravesical BCG.We congratulate Christiaan...
New publication: Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin
Florus C de Jong 1, Teemu D Laajala 2 3, Robert F Hoedemaeker 4, Kimberley R Jordan 5, Angelique C J van der Made 6, Egbert R Boevé 7, Deric K E van der Schoot 8, Bart Nieuwkamer 9, Emiel A M Janssen 10, Tokameh Mahmoudi 1 6, Joost L Boormans 1, Dan...
New publication: Differences between brain responses to peroneal electrical transcutaneous neuromodulation and transcutaneous tibial nerve stimulation, two treatments for overactive bladder
Jan Krhut 1 2, Jaroslav Tintěra 3, Michal Rejchrt 4, Barbora Skugarevská 1 2, Roman Zachoval 5, Peter Zvara 6 7, Bertil F M Blok 8 Abstract Objectives: To compare brain responses to peroneal electrical transcutaneous neuromodulation (peroneal eTNM®) and...
New publication: Shifting risk-stratified early prostate cancer detection to a primary healthcare setting
Renée Hogenhout 1, Daniël F Osses 1, Arnout R Alberts 1, Hanne G Buizer-Rijksen 2, Sebastiaan Remmers 1, Monique J Roobol 1 Abstract Objective: To evaluate the feasibility of multivariable risk stratification for early prostate cancer (PCa) detection in a primary...
New publication: Active Surveillance for Prostate Cancer: Past, Current, and Future Trends
Ivo I de Vos 1, Henk B Luiting 1, Monique J Roobol 1 Abstract In response to the rising incidence of indolent, low-risk prostate cancer (PCa) due to increased prostate-specific antigen (PSA) screening in the 1990s, active surveillance (AS) emerged as a treatment...
New publication: A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines
Joep J de Jong 1, Olga M Pijpers 2, Kim E M van Kessel 2, Joost L Boormans 2, Wim Van Criekinge 3, Ellen C Zwarthoff 4, Yair Lotan 5 Abstract Background: According to the recent American Urological Association (AUA) guideline on hematuria, patients are stratified into...
New publication: Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer
Sebastiaan Remmers, Monique J. Roobol, et al. Abstract Background The European Association of Urology guidelines recommend a risk-based strategy for prostate cancer screening based on the first prostate-specific antigen (PSA) level and age. Objective To analyze the...